Ostem Implant "June 28 Extraordinary General Meeting Convened · Delisting Application Submitted"

Ostem Implant, a KOSDAQ-listed company with the private equity consortium MBK Partners and Unison Capital Korea (UCK) as its largest shareholders, will begin the formal delisting process on the 28th of next month.

[Image source=Yonhap News]

Ostem Implant announced that on the 18th, its board of directors resolved to convene an extraordinary general meeting of shareholders for delisting on the 28th of next month at its headquarters in Gangseo-gu, Seoul. If the delisting approval agenda passes at the extraordinary general meeting, Ostem Implant plans to apply for delisting with the Korea Exchange.

The largest shareholder consortium of Ostem Implant, MBK Partners and UCK, operating under Dentistry Investment, has been pursuing a voluntary delisting through a tender offer. After conducting a second tender offer, their current shareholding ratio stands at 96.1%.

When the largest shareholder of a KOSDAQ-listed company applies for voluntary delisting, the Exchange’s Corporate Evaluation Committee decides on delisting by considering whether the largest shareholder’s shareholding ratio and tender offer conditions meet the standards for public interest realization and investor protection.

Ostem Implant explained, "Depending on the Exchange’s review results of the delisting application, delisting will proceed, and if minority shareholders remain at that time, the largest shareholder (Dentistry Investment) plans to purchase shares from minority shareholders wishing to sell during the orderly trading period and for a certain period (expected to be six months) after delisting." The minority shareholders’ shareholding ratio in Ostem Implant is 3.9%.

This content was produced with the assistance of AI translation services.